Nothing Special   »   [go: up one dir, main page]

AR120259A1 - AAV3B VARIANTS WITH ENHANCED PRODUCTION YIELD AND LIVER TROPISM - Google Patents

AAV3B VARIANTS WITH ENHANCED PRODUCTION YIELD AND LIVER TROPISM

Info

Publication number
AR120259A1
AR120259A1 ARP200102894A ARP200102894A AR120259A1 AR 120259 A1 AR120259 A1 AR 120259A1 AR P200102894 A ARP200102894 A AR P200102894A AR P200102894 A ARP200102894 A AR P200102894A AR 120259 A1 AR120259 A1 AR 120259A1
Authority
AR
Argentina
Prior art keywords
production yield
enhanced production
liver tropism
aav3b
variants
Prior art date
Application number
ARP200102894A
Other languages
Spanish (es)
Inventor
James M Wilson
Qiang Wang
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Publication of AR120259A1 publication Critical patent/AR120259A1/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

En el presente documento se presentan cápsides de AAV y rAAV que las comprenden. En una realización, vectores que emplean una cápside de AAV descrita exhiben transducción aumentada en un tejido seleccionado en comparación con un AAV de la técnica anterior.Presented herein are AAV and rAAV capsids comprising them. In one embodiment, vectors employing a disclosed AAV capsid exhibit increased transduction in a selected tissue compared to a prior art AAV.

ARP200102894A 2019-10-21 2020-10-20 AAV3B VARIANTS WITH ENHANCED PRODUCTION YIELD AND LIVER TROPISM AR120259A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962924112P 2019-10-21 2019-10-21

Publications (1)

Publication Number Publication Date
AR120259A1 true AR120259A1 (en) 2022-02-09

Family

ID=80782191

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP200102894A AR120259A1 (en) 2019-10-21 2020-10-20 AAV3B VARIANTS WITH ENHANCED PRODUCTION YIELD AND LIVER TROPISM

Country Status (1)

Country Link
AR (1) AR120259A1 (en)

Similar Documents

Publication Publication Date Title
PE20212334A1 (en) NOVEL AAV CAPSIDES AND COMPOSITIONS CONTAINING THEM
EA202090332A1 (en) IMPROVED AAV CAPSIDE PRODUCTION IN INSECT CELLS
AR115097A1 (en) ADENO-ASSOCIATED VIRAL VECTORS TARGETING THE LIVER
PE20190129A1 (en) VARIANT CAPSIDS OF ADENO-ASSOCIATED VIRUSES AND METHODS OF USE OF THESE
CL2020001360A1 (en) Variant adeno-associated virus capsids and their use to inhibit angiogenesis.
PE20211419A1 (en) RECOMBINANT VIRAL VECTORS AND NUCLEIC ACIDS TO PRODUCE THEM
BR112019001532A2 (en) innovative adeno-associated virus capsid proteins
MX2023001863A (en) Novel aav capsids and compositions containing same.
UY38733A (en) ARNI CONSTRUCTIONS TO INHIBIT THE EXPRESSION OF SCAP AND METHODS OF USING THEM
DK3740222T3 (en) Modified RAAV capsid protein for gene therapy
BR112023022318A2 (en) AAV CAPSIDS AND THEIR USE
UY37376A (en) ARNI CONSTRUCTIONS TO INHIBIT EXPRESSION OF ASGR1 AND METHODS FOR USE
UY37863A (en) ADENOASOCIATED VIRUS (AAV) WITH MODIFIED PHOSPHOLIPASE DOMAIN
MX2021012311A (en) Variant aav capsids for intravitreal delivery.
EP4019642A4 (en) Isolated modified vp1 capsid protein of aav5
WO2018191363A8 (en) Targeted combination therapy
CO2023002966A2 (en) iRNA constructs and methods to inhibit marc1 expression
AR120259A1 (en) AAV3B VARIANTS WITH ENHANCED PRODUCTION YIELD AND LIVER TROPISM
CO2022010227A2 (en) Modified adeno-associated virus capsid proteins for ocular gene therapy and methods of using same
CL2021002842A1 (en) Inhibitory double-stranded nucleic acid molecules with shortened sense strands
CR10116A (en) ENZYMES FOR REDUCED IMMUNOLOGICAL STRESS
CO2017005830A2 (en) Vaccine compositions for dengue virus
ECSP24013075A (en) ISOLATED MODIFIED AAV5 CAPSID PROTEIN VP1
EA202192955A1 (en) NEW AAV CAPSIDS AND COMPOSITIONS CONTAINING THEM
MX2024009186A (en) Aav capsids for improved heart transduction and detargeting of liver.